Nemaura Medical Inc.
NMRDDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001602078
Nemaura Medical Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Jan 9, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $280.9K in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Nemaura Medical Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NMRD is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 21
- −1 vs. Q3 2023
- Shares held
- 1.28M
- −938.8K (−42.4%) vs. Q3 2023
- Total value
- $280.9K
- −$417.7K (−59.8%) vs. Q3 2023
- New holders
- 3
- 3 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $1.85K |
| Q4 2023 | 21 | $280.9K |
| Q3 2023 | 22 | $698.6K |
| Q2 2023 | 15 | $2.61M |
| Q1 2023 | 16 | $2.88M |
| Q4 2022 | 16 | $1.39M |
| Q3 2022 | 20 | $1.71M |
| Q2 2022 | 19 | $2.16M |
| Q1 2022 | 17 | $3.70M |
| Q4 2021 | 17 | $2.29M |
| Q3 2021 | 17 | $3.62M |
| Q2 2021 | 29 | $10.8M |
| Q1 2021 | 30 | $8.29M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Nemaura Medical Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 845,060 | $185.1K | 0.00% | −997,505−54.1% | Reduced |
| Vanguard Group Inc | 126,682 | $27.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 107,897 | $24.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 53,666 | $12.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 41,693 | $9.38K | 0.00% | +41,693 | New |
| Northern Trust Corp | 26,737 | $5.86K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 21,328 | $4.80K | 0.00% | +21,328 | New |
| Two Sigma Securities, LLC | 17,403 | $3.81K | 0.00% | +17,403 | New |
| UBS Group AG | 13,926 | $3.05K | 0.00% | +13,841+16,283.5% | Added |
| Tower Research Capital LLC (TRC) | 11,872 | $2.60K | 0.00% | −68−0.6% | Reduced |
| Wells Fargo & Company | 4,163 | $912 | 0.00% | +5+0.1% | Added |
| BlackRock Inc. | 3,542 | $775 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 1,950 | $427 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 360 | $79 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 100 | $22 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12 | $3 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 8 | $2 | 0.00% | 00.0% | Unchanged |
| Salomon & Ludwin, LLC | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Hazlett, Burt & Watson, Inc. | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 491 | $0 | 0.00% | +223+83.2% | Added |
| Ronald Blue Trust, Inc. | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,230−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,213−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,814−100.0% | Sold out |